#GoldmanSachsBullishOnCXMT

Goldman Sachs has put a major new spotlight on China’s semiconductor sector with a bullish initiation on ChangXin Memory Technologies (CXMT), assigning the company a Buy rating and a 12-month price target of CNY 129. The report, dated August 23, arrives less than a month after CXMT’s blockbuster Shanghai STAR Market debut and comes at a time when AI-driven memory demand, tight DRAM supply and China’s push for semiconductor self-sufficiency are reshaping the global memory industry.

The most important part of the Goldman thesis is not simply the CNY 129 target. It is the bank’s view that three structural trends could develop simultaneously: rising AI-related memory demand in China, aggressive CXMT capacity expansion and increasing domestic substitution in DRAM. Goldman reportedly expects CXMT’s monthly wafer capacity to rise from around 270,000 wafers in 2026 to 447,000 in 2028 and 665,000 by 2030. If achieved, that would represent more than a doubling of capacity over four years.

That capacity outlook is particularly significant because Goldman estimates CXMT could eventually supply approximately 50% of China’s DRAM demand by 2028. This should not be interpreted as CXMT already holding 50% market share; the estimate refers to potential future supply capability. The distinction is important because the company is still scaling production, improving yields and expanding its product portfolio.

CXMT’s market performance has already demonstrated how aggressively investors are pricing the China-memory story. The company debuted on Shanghai’s STAR Market on July 27 at CNY 49.50, compared with an IPO price of CNY 8.66, representing an opening gain of more than 470%. It subsequently climbed to record levels, with its market capitalization exceeding CNY 4 trillion in August as investors responded to AI memory demand, domestic substitution and a global shortage of memory chips.

This creates an interesting contradiction for investors. CXMT is still a relatively new public company, yet the market has already assigned it a valuation comparable with some of the world's largest semiconductor businesses. The bullish argument is that the current memory cycle is fundamentally different because AI infrastructure is generating extraordinary demand for DRAM, HBM and high-performance memory. The bearish argument is that CXMT's valuation may be pricing in years of successful capacity expansion before those earnings are actually delivered.

HBM is therefore one of the most important pieces of the long-term thesis. Goldman reportedly expects HBM to rise from around 2% of CXMT revenue in 2026 to 27% by 2030. If that forecast materializes, CXMT would be moving beyond conventional DRAM and increasingly participating in the higher-value AI memory market. But this is also one of the biggest execution risks: HBM requires advanced packaging, demanding qualification processes, high yields and strong customer relationships.

There is already an important reality check in CXMT’s IPO documentation. The company raised approximately CNY 57.92 billion, or around $8.6 billion, in its Shanghai listing, but its prospectus did not identify a dedicated HBM project among the named uses of funds. A large portion of the planned spending was directed toward DRAM technology upgrades, next-generation DRAM research and wafer-line improvements. That means investors should separate Goldman’s longer-term HBM expectations from CXMT’s currently funded production roadmap.

The global implications are even bigger. CXMT’s expansion could increase competition in conventional DRAM and potentially challenge the economics of established suppliers such as Micron, SK hynix and Samsung. However, the impact will not necessarily be uniform across the memory market. Conventional DDR5 and LPDDR could face more competitive pressure as Chinese capacity grows, while advanced HBM remains a much more technically demanding segment.

This distinction matters because the current AI boom is creating a memory shortage across multiple categories. Research highlighted recently suggests that demand is spilling beyond HBM into conventional DRAM and NAND, keeping the broader memory cycle unusually strong. That environment gives CXMT an attractive backdrop for expansion, but it also means the company is entering the market at a point when memory valuations and expectations are already extremely elevated.

Goldman’s financial assumptions are ambitious as well. The report reportedly sees CXMT’s gross margin potentially rising from around 41% in 2025 to 82% in 2030. Such an expansion would require sustained DRAM pricing, successful production ramp-up, improving yields, customer qualification and a significant shift toward higher-value products. If any of those assumptions fail, the CNY 129 target could become much harder to justify.

There is another major factor that cannot be ignored: geopolitics. China’s semiconductor industry is aggressively pursuing technological self-sufficiency while U.S. restrictions continue to influence access to advanced semiconductor equipment and technologies. CXMT’s progress therefore has strategic significance beyond its financial statements. A successful domestic memory supply chain could reduce China’s dependence on foreign DRAM suppliers, but restrictions on advanced equipment could also complicate the pace at which CXMT reaches its long-term technology targets.

For the global memory trade, this creates two simultaneous narratives. In the short term, AI demand is supporting prices and profitability across the industry. In the longer term, new capacity from CXMT and other Chinese memory producers could increase supply and eventually challenge the pricing power of established suppliers.

That is why Goldman Sachs’ bullish call should be viewed as a long-term execution thesis rather than a guaranteed short-term price signal. CXMT has already delivered an extraordinary post-IPO rally, so investors now need to watch whether operational growth can catch up with the valuation.

The numbers tell the story: CNY 129 Goldman target, 270K wafers/month in 2026, 665K targeted by 2030, potential 50% China DRAM supply capability by 2028 and HBM revenue contribution potentially reaching 27% by 2030.

CXMT is no longer simply China’s emerging memory challenger. It is becoming one of the most important tests of whether China can build a globally competitive DRAM business while the AI revolution is simultaneously pushing memory demand to unprecedented levels.

Goldman is bullish on the destination. The market now has to decide whether CXMT can execute the journey. @Gate_Square